G
Gemina Laboratories Ltd
CNSX:GLAB
Gemina Laboratories Ltd
CNSX:GLAB
Price:
0.04
CAD
33.33%
Market Cap:
CA$3.1m
Income Statement
Earnings Waterfall
Gemina Laboratories Ltd
Gemina Laboratories Ltd
Income Statement
Gemina Laboratories Ltd
Gemina Laboratories Ltd
Currency: CAD
| Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | Jan-2024 | Apr-2024 | Jul-2024 | Oct-2024 | Jan-2025 | Apr-2025 | Jul-2025 | Oct-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-93%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(5)
|
(5)
|
(5)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(4)
|
(4)
|
(4)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Research & Development |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(5)
N/A
|
(5)
-5%
|
(5)
+5%
|
(3)
+45%
|
(3)
-26%
|
(4)
-11%
|
(4)
0%
|
(4)
+3%
|
(3)
+9%
|
(4)
-21%
|
(4)
-1%
|
(4)
0%
|
(4)
-15%
|
(3)
+27%
|
(3)
+14%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(8)
N/A
|
(9)
-16%
|
(9)
+3%
|
(6)
+32%
|
(7)
-16%
|
(6)
+6%
|
(6)
+1%
|
(5)
+19%
|
(4)
+17%
|
(5)
-5%
|
(4)
+7%
|
(4)
+4%
|
(5)
-19%
|
(3)
+28%
|
(3)
+15%
|
|
| Net Income | ||||||||||||||||
| Income from Continuing Operations |
(8)
|
(9)
|
(9)
|
(6)
|
(7)
|
(6)
|
(6)
|
(5)
|
(4)
|
(5)
|
(4)
|
(4)
|
(5)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(8)
N/A
|
(9)
-16%
|
(9)
+3%
|
(6)
+32%
|
(7)
-16%
|
(6)
+6%
|
(6)
+1%
|
(5)
+19%
|
(4)
+17%
|
(5)
-5%
|
(4)
+7%
|
(4)
+4%
|
(5)
-19%
|
(3)
+28%
|
(3)
+15%
|
|
| EPS (Diluted) |
-0.16
N/A
|
-0.15
+6%
|
-0.13
+13%
|
-0.1
+23%
|
-0.11
-10%
|
-0.1
+9%
|
-0.09
+10%
|
-0.07
+22%
|
-0.06
+14%
|
-0.06
N/A
|
-0.06
N/A
|
-0.06
N/A
|
-0.06
N/A
|
-0.05
+17%
|
-0.04
+20%
|
|
Switch to:
Switch to:
See Also
Discover More
